![]() EdiGENE EdiGENE is a biotech company that develops therapeutics using its proprietary technology CRISPR-GNDM (guide nucleotide-directed modulation). | ![]() StrideBio StrideBio is a gene therapy company focused on creating and developing novel adeno-associated viral vector technologies and therapeutics for rare diseases. | ![]() Pluri Biotech Pluri Biotech (פלורי ביוטק בע"מ, formerly Pluristem Therapeutics) is a clinical-stage biotherapy company developing cell therapies. | |||
Founding Date | Founding Date 2015 | Founding Date 2015 | Founding Date 2018 | Founding Date 2022 | Founding Date 2003 |
Type | Type Private | Type Private | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Cambridge, US HQ | Locations US HQ | Locations South San Francisco, US HQ Redwood City, US South San Francisco, US | Locations San Mateo, US HQ | Locations Haifa, IL HQ Potsdam, DE |
Employees | Employees 49 | Employees 5 | Employees 121 | Employees 40 | Employees 106 |
Financial | |||||
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $6.3m (FY, 2025) | Cost of goods N/A | Cost of goods $682k (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income ($131.1m) (FY, 2025) | Net income N/A | Net income ($23.3m) (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round $ 22m (about 5 years ago) | Latest funding round $ 81.5m (about 5 years ago) | Latest funding round N/A | Latest funding round $ 50m (about 3 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 143.5m | Total funding raised $ 97.2m | Total funding raised $ 191m | Total funding raised $ 50m | Total funding raised $ 78.4m |

StrideBio is a gene therapy company focused on creating and developing novel adeno-associated viral vector technologies and therapeutics for rare diseases.
View company
Maze Therapeutics is a clinical-stage biopharmaceutical company.
View company
EpiBiologics is a company that provides a protein degradation platform.
View company
Pluri Biotech (פלורי ביוטק בע"מ, formerly Pluristem Therapeutics) is a clinical-stage biotherapy company developing cell therapies.
View company